Intravenous regional block is similar to sympathetic ganglion block for pain management in patients with complex regional pain syndrome type I

Detalhes bibliográficos
Autor(a) principal: Nascimento,M.S.A.
Data de Publicação: 2010
Outros Autores: Klamt,J.G., Prado,W.A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010001200014
Resumo: Sympathetic ganglion block (SGB) or intravenous regional block (IVRB) has been recommended for pain management in patients with complex regional pain syndrome type I (CRPS-I). Forty-five patients were initially selected but only 43 were accepted for the study. The present study evaluated the efficacy of IVRB produced by combining 70 mg lidocaine with 30 µg clonidine (14 patients, 1 male/13 females, age range: 27-50 years) versus SGB produced by the injection of 70 mg lidocaine alone (14 patients, 1 male/13 females, age range: 27-54 years) or combined with 30 µg clonidine (15 patients, 1 male/14 females, age range: 25-50 years) into the stellate ganglion for pain management in patients with upper extremity CRPS-I. Each procedure was repeated five times at 7-day intervals, and pain intensity and duration were measured using a visual analog scale immediately before each procedure. A progressive and significant reduction in pain scores and a significant increase in the duration of analgesia were observed in all groups following the first three blocks, but no further improvement was obtained following the last two blocks. Drowsiness, the most frequent side effect, and dry mouth occurred only in patients submitted to SGB with lidocaine combined with clonidine. The three methods were similar regarding changes in pain intensity and duration of analgesia. However, IVRB seems to be preferable to SGB due to its easier execution and lower risk of undesirable effects.
id ABDC-1_a9cdbaec4f3fbae953edf2b13ffb3a17
oai_identifier_str oai:scielo:S0100-879X2010001200014
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling Intravenous regional block is similar to sympathetic ganglion block for pain management in patients with complex regional pain syndrome type IClonidineComplex regional pain syndrome type IIntravenous regional blockLidocaineStellate ganglion blockSympathetic ganglion blockSympathetic ganglion block (SGB) or intravenous regional block (IVRB) has been recommended for pain management in patients with complex regional pain syndrome type I (CRPS-I). Forty-five patients were initially selected but only 43 were accepted for the study. The present study evaluated the efficacy of IVRB produced by combining 70 mg lidocaine with 30 µg clonidine (14 patients, 1 male/13 females, age range: 27-50 years) versus SGB produced by the injection of 70 mg lidocaine alone (14 patients, 1 male/13 females, age range: 27-54 years) or combined with 30 µg clonidine (15 patients, 1 male/14 females, age range: 25-50 years) into the stellate ganglion for pain management in patients with upper extremity CRPS-I. Each procedure was repeated five times at 7-day intervals, and pain intensity and duration were measured using a visual analog scale immediately before each procedure. A progressive and significant reduction in pain scores and a significant increase in the duration of analgesia were observed in all groups following the first three blocks, but no further improvement was obtained following the last two blocks. Drowsiness, the most frequent side effect, and dry mouth occurred only in patients submitted to SGB with lidocaine combined with clonidine. The three methods were similar regarding changes in pain intensity and duration of analgesia. However, IVRB seems to be preferable to SGB due to its easier execution and lower risk of undesirable effects.Associação Brasileira de Divulgação Científica2010-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010001200014Brazilian Journal of Medical and Biological Research v.43 n.12 2010reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/S0100-879X2010007500123info:eu-repo/semantics/openAccessNascimento,M.S.A.Klamt,J.G.Prado,W.A.eng2010-12-13T00:00:00Zoai:scielo:S0100-879X2010001200014Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2010-12-13T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv Intravenous regional block is similar to sympathetic ganglion block for pain management in patients with complex regional pain syndrome type I
title Intravenous regional block is similar to sympathetic ganglion block for pain management in patients with complex regional pain syndrome type I
spellingShingle Intravenous regional block is similar to sympathetic ganglion block for pain management in patients with complex regional pain syndrome type I
Nascimento,M.S.A.
Clonidine
Complex regional pain syndrome type I
Intravenous regional block
Lidocaine
Stellate ganglion block
Sympathetic ganglion block
title_short Intravenous regional block is similar to sympathetic ganglion block for pain management in patients with complex regional pain syndrome type I
title_full Intravenous regional block is similar to sympathetic ganglion block for pain management in patients with complex regional pain syndrome type I
title_fullStr Intravenous regional block is similar to sympathetic ganglion block for pain management in patients with complex regional pain syndrome type I
title_full_unstemmed Intravenous regional block is similar to sympathetic ganglion block for pain management in patients with complex regional pain syndrome type I
title_sort Intravenous regional block is similar to sympathetic ganglion block for pain management in patients with complex regional pain syndrome type I
author Nascimento,M.S.A.
author_facet Nascimento,M.S.A.
Klamt,J.G.
Prado,W.A.
author_role author
author2 Klamt,J.G.
Prado,W.A.
author2_role author
author
dc.contributor.author.fl_str_mv Nascimento,M.S.A.
Klamt,J.G.
Prado,W.A.
dc.subject.por.fl_str_mv Clonidine
Complex regional pain syndrome type I
Intravenous regional block
Lidocaine
Stellate ganglion block
Sympathetic ganglion block
topic Clonidine
Complex regional pain syndrome type I
Intravenous regional block
Lidocaine
Stellate ganglion block
Sympathetic ganglion block
description Sympathetic ganglion block (SGB) or intravenous regional block (IVRB) has been recommended for pain management in patients with complex regional pain syndrome type I (CRPS-I). Forty-five patients were initially selected but only 43 were accepted for the study. The present study evaluated the efficacy of IVRB produced by combining 70 mg lidocaine with 30 µg clonidine (14 patients, 1 male/13 females, age range: 27-50 years) versus SGB produced by the injection of 70 mg lidocaine alone (14 patients, 1 male/13 females, age range: 27-54 years) or combined with 30 µg clonidine (15 patients, 1 male/14 females, age range: 25-50 years) into the stellate ganglion for pain management in patients with upper extremity CRPS-I. Each procedure was repeated five times at 7-day intervals, and pain intensity and duration were measured using a visual analog scale immediately before each procedure. A progressive and significant reduction in pain scores and a significant increase in the duration of analgesia were observed in all groups following the first three blocks, but no further improvement was obtained following the last two blocks. Drowsiness, the most frequent side effect, and dry mouth occurred only in patients submitted to SGB with lidocaine combined with clonidine. The three methods were similar regarding changes in pain intensity and duration of analgesia. However, IVRB seems to be preferable to SGB due to its easier execution and lower risk of undesirable effects.
publishDate 2010
dc.date.none.fl_str_mv 2010-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010001200014
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010001200014
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0100-879X2010007500123
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.43 n.12 2010
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302939042676736